Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA plus danazol versus danazol for refractory immune thrombocytopenia
ChiCTR-TRC-12002424Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tretinoin and danazol in immune thrombocytopenia (ITP) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Platelet count. Started Jun 2011; status: completed.
02
Drugs
tretinoindanazol
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-TRC-12002424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002424.